Volume 32, Issue 20 (February 3, 2024)

For the issue, subscribers click here.


Private Equity Lab Tool Deal Values Fall in 2023

Executive Briefing

The latest on Bruker, Datacolor, Calibre Scientific and more


IBO Stock Indexes Perform Tepidly in January

Market Profile

Electron Paramagnetic Resonance Spectroscopy (EPR)

Industry Watch

Healthcare: VC Investments Decline

Biopharma: Total M&A Value Robust in 2023

Cell and Gene Therapy: Capacity Bottlenecks

Region Watch

China: Economy Jeopardizes S&T Spending

Germany: Biotech Outlook Improves Slightly

EU: IVD Compliance Update


Broad-Based Companies


Life Science Instruments

Gene-Based Analysis

Cell-Based Analysis

Protein-Based AnalysisMaterials Characterization

Bottom Line

Companies financial results

< | >